Literature DB >> 186129

Heterogeneity of carcinoembryonic antigen. Implications on its role as a tumour marker substance.

G T Rogers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186129     DOI: 10.1016/0304-419x(76)90007-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  8 in total

1.  An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract.

Authors:  K Kapsopoulou-Dominos; F A Anderer
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  [Demonstration of circulating CEA or CEA-like antigens and immunoglobulin G containing immune complexes in colorectal carcinoma].

Authors:  R Pompecki
Journal:  Klin Wochenschr       Date:  1984-04-02

3.  New lectin receptors in carcinoembryonic antigen (CEA).

Authors:  G Wintzer; G Uhlenbruck; G Steinhausen; H Carmann
Journal:  Experientia       Date:  1978-02-15

4.  Carcinoembryonic antigen in retinoblastoma. An immunohistochemical study.

Authors:  T Kivelä; A Tarkkanen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

5.  Antigenic expression of heat-stable and heat-labile binding sites on carcinoembryonic antigen.

Authors:  P A Keep; A R Gibbons; G T Rogers
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

6.  Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid.

Authors:  P A Keep; B A Leake; G T Rogers
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

7.  Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum.

Authors:  G T Rogers; G A Rawlins; P A Keep; E H Cooper; K D Bagshawe
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

8.  Somatic-cell hybrids producing antibodies against CEA.

Authors:  G T Rogers; G A Rawlins; K D Bagshawe
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.